PITAVASTATIN CALCIUM | A205932 | ORIENT PHARMA CO LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Kowa Company, LTD. et al v. Orient Pharma Co., LTD. 3 patentsANDA 205932pitavastatin calcium | N.D. Ill. | 2014-05-07 | Terminated 2014-11-26 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$1.27
per ea
Lowest NADAC/Unit
$1.15
per ea
Brand NDCs
0
Generic NDCs
3
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00480363398PITAVASTATIN 4 MG TABLET | $1.27 | EA | Generic | — | 2026-06-17 |
| 00480363198PITAVASTATIN 1 MG TABLET | $1.20 | EA | Generic | — | 2026-06-17 |
| 00480363298PITAVASTATIN 2 MG TABLET | $1.15 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.